Rebalix
Xtrackers · sheet of 10 September 2026
Xtrackers · sheet of 10 September 2026ETF sheet · official issuer and register data
Xtrackers Artificial Intelligence Big Data UCITS ETF 1c
IE00BGV5VN51 · IE00BGV5VN51 · USD · domicile Ireland
Equity · North America · TechnologySFDR art. 8
Index tracked: Nasdaq Global Artificial Intelligence and Big Data Total Net Return Index (USD)
- TER
- 0.35%+ trans. 0.12%
- Fund size
- 7.7 bn EUR
- Tracking difference
- −0.35%3-year avg
- 🇮🇹 tax rate
- —white list not published
- Replication
- Physical
- Income
- Accumulating
Launch 29 Jan 2019 · costs from the KID as of 2 Sept 2026 · 110 securities held · 10 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 4 Aug 2026
The fund is passively managed.
INVESTMENT OBJECTIVE:
The aim is for your investment to track the performance before fees and expenses of the Nasdaq Global Artificial Intelligence and Big Data Index (index).
DESCRIPTION OF INDEX:
The index is designed to reflect the performance of the shares of companies from global developed and emerging markets that have material exposure to themes related to artificial intelligence, data processing, and data security that meet certain environmental, social and governance (ESG) criteria. Nasdaq applies a screening…
Performance since series start (in euro) — base 100
29 Jan 2019 → 8 Sept 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
Returns in euro
| 1 year | +48.2% |
| 3 years | +127.5% |
| 5 years | +150.1% |
| 10 years | series too young |
| Since series start | +376.4% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 22.68% | 20.65% | 21.70% |
| Max drawdown | −16.43% | −23.56% | −41.00% |
| Sharpe | 1.67 | 1.38 | 0.82 |
| Sortino | 2.44 | 2.00 | 1.19 |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · IE00BGV5VN51 · IE00BGV5VN511
RebalixIE00BGV5VN51 · IE00BGV5VN51 · sheet of 10 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years · from issuer-declared series
| Year | Fund | Index | TD |
|---|---|---|---|
| 2025 | +29.47% | +29.74% | −0.28% |
| 2024 | +26.74% | +27.03% | −0.29% |
| 2023 | +67.52% | +67.99% | −0.47% |
| 2022 | −34.75% | −34.21% | −0.54% |
| 2021 | +24.04% | +24.44% | −0.40% |
Holdings
Portfolio as declared by the issuer · 2 Sept 2026 · 110 securities · top-10 weight = 44.3%
| Top holdings | Weight |
|---|---|
| 5.9% | |
| 4.9% | |
| 4.8% | |
| 4.7% | |
| 4.5% | |
| 4.1% | |
| 4.1% | |
| 3.9% | |
| 3.7% | |
| 3.7% |
Countries (% of fund)
Sectors (% of fund)
Listing venues
ESMA register (FIRDS) and official exchange lists
XAIX · Borsa Italiana (ETFplus), Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
— · Nasdaq Stockholm
+ 21 unmapped venues (MTF, RFQ, professional)
Official documents
Clickable links in the PDF
The live sheet, always up to date
rebalix.com/en/etf/IE00BGV5VN51
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/IE00BGV5VN51
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · IE00BGV5VN51 · IE00BGV5VN512